All In MedTech

FDA Clearance Tracker · P830061-S189

CapSure Sense Lead

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 22, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 22, 2020

Approved

Time to decision

19 days

Received Dec 3, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P830061-S189
Device name
CapSure Sense Lead
Applicant location
Mounds View, MN
Received
Dec 3, 2020
Decided
Dec 22, 2020
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P830061

Device type

Device class
Class III

Every decision under product code NVN

FDA's approval statement

As written in FDA's record.

Manufacturing site located at Medtronic Singapore Operations: 49 Changi South Avenue 2, Nasaco Tech Centre, Singapore 486056.

Source documents

Other decisions for Medtronic Cardiac Rhythm Disease Management

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.